577 related articles for article (PubMed ID: 22343221)
41. [An alpha 1-antitrypsin aerosol in the treatment of cystic fibrosis].
Ferrer Calvete J; Aznar Lucea J; Morales Marín P; Pereda Pérez A; Llopis Carles R; Ribes Koninckx C; Ferrer González P; Marco Martínez V
An Esp Pediatr; 1996 Feb; 44(2):109-11. PubMed ID: 8830566
[TBL] [Abstract][Full Text] [Related]
42. Using a Caesalpinia echinata Lam. protease inhibitor as a tool for studying the roles of neutrophil elastase, cathepsin G and proteinase 3 in pulmonary edema.
Cruz-Silva I; Neuhof C; Gozzo AJ; Nunes VA; Hirata IY; Sampaio MU; Figueiredo-Ribeiro Rde C; Neuhof H; Araújo Mda S
Phytochemistry; 2013 Dec; 96():235-43. PubMed ID: 24140156
[TBL] [Abstract][Full Text] [Related]
43. Aerosolized rhDNase in cystic fibrosis: effect on leucocyte proteases in sputum.
Rochat T; Pastore FD; Schlegel-Haueter SE; Filthuth I; Auckenthaler R; Belli D; Suter S
Eur Respir J; 1996 Nov; 9(11):2200-6. PubMed ID: 8947060
[TBL] [Abstract][Full Text] [Related]
44. Protection of lung epithelial cells from protease-mediated injury by trappin-2 A62L, an engineered inhibitor of neutrophil serine proteases.
Tanga A; Saidi A; Jourdan ML; Dallet-Choisy S; Zani ML; Moreau T
Biochem Pharmacol; 2012 Jun; 83(12):1663-73. PubMed ID: 22465040
[TBL] [Abstract][Full Text] [Related]
45. Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease.
Rubio F; Cooley J; Accurso FJ; Remold-O'Donnell E
Thorax; 2004 Apr; 59(4):318-23. PubMed ID: 15047952
[TBL] [Abstract][Full Text] [Related]
46. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum.
Hansen G; Schuster A; Zubrod C; Wahn V
Respiration; 1995; 62(3):117-24. PubMed ID: 7569330
[TBL] [Abstract][Full Text] [Related]
47. Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.
Costello CM; O'Connor CM; Finlay GA; Shiels P; FitzGerald MX; Hayes JP
Thorax; 1996 Jun; 51(6):619-23. PubMed ID: 8693445
[TBL] [Abstract][Full Text] [Related]
48. Staphylococcus aureus protects its immune-evasion proteins against degradation by neutrophil serine proteases.
Stapels DA; Kuipers A; von Köckritz-Blickwede M; Ruyken M; Tromp AT; Horsburgh MJ; de Haas CJ; van Strijp JA; van Kessel KP; Rooijakkers SH
Cell Microbiol; 2016 Apr; 18(4):536-45. PubMed ID: 26418545
[TBL] [Abstract][Full Text] [Related]
49. Human neutrophils kill Streptococcus pneumoniae via serine proteases.
Standish AJ; Weiser JN
J Immunol; 2009 Aug; 183(4):2602-9. PubMed ID: 19620298
[TBL] [Abstract][Full Text] [Related]
50. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
Vermilyea DM; Crocker AW; Gifford AH; Hogan DA
J Bacteriol; 2021 Jun; 203(13):e0010021. PubMed ID: 33927050
[TBL] [Abstract][Full Text] [Related]
51. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis.
Schuster A; Haarmann A; Wahn V
Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S59-60. PubMed ID: 7537567
[TBL] [Abstract][Full Text] [Related]
52. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
53. Serine proteases degrade airway mucins in cystic fibrosis.
Henke MO; John G; Rheineck C; Chillappagari S; Naehrlich L; Rubin BK
Infect Immun; 2011 Aug; 79(8):3438-44. PubMed ID: 21646446
[TBL] [Abstract][Full Text] [Related]
54. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis.
Delacourt C; Le Bourgeois M; D'Ortho MP; Doit C; Scheinmann P; Navarro J; Harf A; Hartmann DJ; Lafuma C
Am J Respir Crit Care Med; 1995 Aug; 152(2):765-74. PubMed ID: 7633740
[TBL] [Abstract][Full Text] [Related]
55. Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
Cipolla D; Zhang J; Korkmaz B; Chalmers JD; Basso J; Lasala D; Fernandez C; Teper A; Mange KC; Perkins WR; Sullivan EJ
Respir Res; 2023 May; 24(1):133. PubMed ID: 37198686
[TBL] [Abstract][Full Text] [Related]
56. The Pig: A Relevant Model for Evaluating the Neutrophil Serine Protease Activities during Acute Pseudomonas aeruginosa Lung Infection.
Chevaleyre C; Riou M; Bréa D; Vandebrouck C; Barc C; Pezant J; Melo S; Olivier M; Delaunay R; Boulesteix O; Berthon P; Rossignol C; Burlaud Gaillard J; Becq F; Gauthier F; Si-Tahar M; Meurens F; Berri M; Caballero-Posadas I; Attucci S
PLoS One; 2016; 11(12):e0168577. PubMed ID: 27992534
[TBL] [Abstract][Full Text] [Related]
57. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
Janusz MJ; Doherty NS
J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
[TBL] [Abstract][Full Text] [Related]
58. Colistin stimulates the activity of neutrophil elastase and Pseudomonas aeruginosa elastase.
Jones A; Elphick H; Pettitt E; Everard ML; Evans GS
Eur Respir J; 2002 Jun; 19(6):1136-41. PubMed ID: 12108869
[TBL] [Abstract][Full Text] [Related]
59. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
Meyer KC; Zimmerman J
J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
[TBL] [Abstract][Full Text] [Related]
60. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
